A P Monaco

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Rewards for organ donation: the time has come
    A P Monaco
    Harvard Medical School, Boston, Massachusetts 02215, USA
    Kidney Int 69:955-7. 2006
  2. ncbi Chimerism in organ transplantation: conflicting experiments and clinical observations
    Anthony P Monaco
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Transplantation 75:13S-16S. 2003
  3. ncbi Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation
    D A Hale
    Division of Organ Transplantation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Transplantation 69:1242-51. 2000
  4. ncbi Porcine islet xenotransplantation utilizing a vascularized bioartificial pancreas
    T Maki
    Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
    Ann Transplant 2:69-71. 1997
  5. ncbi Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation
    A Umemura
    Department of Surgery, Transplant Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    J Immunol 167:3043-8. 2001
  6. ncbi Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion
    A P Monaco
    Harvard Medical School, New England Deaconess Hospital, Boston, MA 02215, USA
    Am J Kidney Dis 33:150-60. 1999
  7. ncbi Prospects and strategies for clinical tolerance
    A P Monaco
    Harvard Medical School, Boston, Massachusetts, USA
    Transplant Proc 36:227-31. 2004
  8. ncbi Tolerance and chimerism: separate and unequal concepts
    A P Monaco
    Harvard Medical School, Boston, Massachusetts, USA
    Transplant Proc 34:1991-7. 2002
  9. ncbi Enteric drainage of a pancreas allograft is safe for patients with celiac sprue
    Mohamed Akoad
    Department of Surgery, Division of Transplantation, The Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Clin Transplant 16:387-8. 2002
  10. ncbi Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720
    Takashi Maki
    The Transplant Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Harvard Institute of Medicine, Boston, MA 02215, USA
    Transplantation 79:1051-5. 2005

Collaborators

Detail Information

Publications37

  1. ncbi Rewards for organ donation: the time has come
    A P Monaco
    Harvard Medical School, Boston, Massachusetts 02215, USA
    Kidney Int 69:955-7. 2006
    ..Such a system would be consistent with similar financial rewards given in our society to recognize instances of personal self-sacrifice and risk taking performed for the benefit of others...
  2. ncbi Chimerism in organ transplantation: conflicting experiments and clinical observations
    Anthony P Monaco
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Transplantation 75:13S-16S. 2003
    ..The presence of class II positive cells in the donor bone marrow inoculum is essential for tolerance induction in these models...
  3. ncbi Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation
    D A Hale
    Division of Organ Transplantation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Transplantation 69:1242-51. 2000
    ..However, reluctance of clinicians to expose recipients to radiation has hampered its clinical application...
  4. ncbi Porcine islet xenotransplantation utilizing a vascularized bioartificial pancreas
    T Maki
    Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
    Ann Transplant 2:69-71. 1997
    ....
  5. ncbi Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation
    A Umemura
    Department of Surgery, Transplant Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    J Immunol 167:3043-8. 2001
    ....
  6. ncbi Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion
    A P Monaco
    Harvard Medical School, New England Deaconess Hospital, Boston, MA 02215, USA
    Am J Kidney Dis 33:150-60. 1999
    ....
  7. ncbi Prospects and strategies for clinical tolerance
    A P Monaco
    Harvard Medical School, Boston, Massachusetts, USA
    Transplant Proc 36:227-31. 2004
    ..Current clinical strategies already being tested in the clinic are briefly reviewed. Certain principles for induction of clinical (operational) tolerance are elaborated...
  8. ncbi Tolerance and chimerism: separate and unequal concepts
    A P Monaco
    Harvard Medical School, Boston, Massachusetts, USA
    Transplant Proc 34:1991-7. 2002
  9. ncbi Enteric drainage of a pancreas allograft is safe for patients with celiac sprue
    Mohamed Akoad
    Department of Surgery, Division of Transplantation, The Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Clin Transplant 16:387-8. 2002
    ..We believe that, when carefully performed, enteric drainage of pancreas allografts is a safe approach for diabetic patients with celiac sprue, and may avert the serious complications associated with bladder drainage...
  10. ncbi Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720
    Takashi Maki
    The Transplant Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Harvard Institute of Medicine, Boston, MA 02215, USA
    Transplantation 79:1051-5. 2005
    ..In this study, the authors investigated whether FTY720 treatment of NOD mice with established insulitis prevents the development of diabetes...
  11. ncbi On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes
    Yingyos Avihingsanon
    Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA, USA
    J Am Soc Nephrol 16:1542-8. 2005
    ..The transcriptional profiling data provide absolutely essential data to the predictive models, particularly with respect to AR and renal function 6 mo posttransplantation...
  12. ncbi Older living donors provide excellent quality kidneys: a single center experience (older living donors)
    Scott R Johnson
    Division of Transplant Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Clin Transplant 19:600-6. 2005
    ..The role of advanced age live donors remains controversial because of decline in glomerular filtration rate and perceived increased risks of perioperative complications...
  13. ncbi Intensive care unit extubation does not preclude extrarenal organ recovery from donors after cardiac death
    Scott R Johnson
    Division of Transplant Surgery, Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Transplantation 80:1244-50. 2005
    ..We have sought to increase the utilization of both renal and extrarenal organs from donors after cardiac death (DCD), including DCD donors with ICU extubation...
  14. ncbi Good samaritan kidney donation
    Paul E Morrissey
    Transplantation 80:1369-73. 2005
  15. ncbi Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder
    Amitabh Gautam
    Division of Organ Transplantation, Rhode Island Hospital, Providence, RI 02903, USA
    Pediatr Transplant 10:613-6. 2006
    ..Later, when the cell-mediated immune response increased, with negative viral load, immunosuppression was gradually increased utilizing the assay to adjust dosing. Presently, there are no signs of PTLD and renal function remains normal...
  16. ncbi The beginning of clinical tolerance in solid organ allografts
    Anthony P Monaco
    The Transplant Center, Beth Israel Deaconess Medical Center, 110 Francis Street-7th Floor, Boston, MA 02215, USA
    Exp Clin Transplant 2:153-61. 2004
    ..Finally, the role of donor bone marrow infusions in facilitating tolerance/hyporesponsiveness induction needs to be studied and expanded...
  17. ncbi Living kidney donation: evolution and technical aspects of donor nephrectomy
    Paul E Morrissey
    Brown Medical School, Rhode Island Hospital, 593 Eddy Street, Providence RI 02903, USA
    Surg Clin North Am 86:1219-35, vii. 2006
    ..The lessons learned from these technical developments are valuable and can be adapted by general surgeons and urologists when called upon to perform nephrectomy for organ donation or kidney disease...
  18. ncbi Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion
    Akira Kanamoto
    Transplant Center, Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Transplantation 78:825-30. 2004
    ..CONCLUSIONS: Chimeric donor cells play a major role in both the early and late phases of transplantation tolerance induced by the ALS, sirolimus, and BMC regimen...
  19. ncbi SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates
    Takashi Maki
    The Transplant Center, Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    Transplantation 85:893-902. 2008
    ..We investigated the effect of a similar regimen in a nonhuman primate (NHP) model...
  20. ncbi Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice
    Takashi Maki
    Transplant Center, Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Transplantation 74:1684-6. 2002
    ..FTY720 prevents allograft rejection with remarkable potency without inducing generalized immunosuppression. We determined the effect of FTY720 on development of autoimmune diabetes in nonobese diabetic (NOD) mice...
  21. ncbi Renal transplant survival from older donors: a single center experience
    Paul E Morrissey
    Division of Organ Transplantation, Rhode Island Hospital, Brown Medical School, Providence, RI 02903, USA
    Arch Surg 139:384-9; discussion 389. 2004
    ..We explored the risk of allograft failure in a single transplantation center with older (55-79 years) vs younger (18-54 years) donors...
  22. ncbi Is there a rational solution to the kidney shortage?
    Anthony P Monaco
    Harvard Medical School, USA
    Med Health R I 90:89-90. 2007
  23. ncbi Introduction of Sir Peter John Morris
    Anthony P Monaco
    Division of Transplantation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Transplantation 82:1587-9. 2006
  24. ncbi Editorial comment: the other consequences of CMV infection
    Anthony P Monaco
    Transplantation 82:S1-2. 2006
  25. ncbi Instant electronic access to randomized controlled trials (RCT)
    Peter J Morris
    Transplantation 84:939. 2007
  26. ncbi Costs of ABO incompatible living donor transplantation are justified
    Peter J Morris
    Transplantation 82:154. 2006
  27. ncbi Editorial comment: a role for alloimmune response mediators in tolerance induction?
    Anthony P Monaco
    Transplantation 84:S1-2. 2007
  28. ncbi Utility of a mathematical nomogram to predict delayed graft function: a single-center experience
    Jonathan A Grossberg
    Rhode Island Hospital, Brown Medical School, and Computer Information Systems, Lifespan/Rhode Island Hospital, Providence, RI, USA
    Transplantation 81:155-9. 2006
    ..Prospective application of a nomogram on a case-by-case basis did not contribute meaningful information that could guide clinical decision-making regarding use, allocation or immunosuppressive regimen aimed at minimizing DGF...
  29. ncbi Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow
    Douglas A Hale
    Division of Organ Transplantation, Beth Israel Deaconess Medcial Center, Boston, Massachusetts, USA
    Transplantation 74:477-84. 2002
    ..These experiments evaluate the mechanisms associated with tolerance in mice treated with sirolimus, antilymphocyte serum (ALS), and donor-specific bone marrow (BM)...
  30. ncbi Management of thrombophilia in renal transplant patients
    Paul E Morrissey
    Department of Surgery, Rhode Island Hospital and Brown University, Providence, RI, USA
    Am J Transplant 2:872-6. 2002
    ..Recommendations for managing thrombophilia in renal transplant recipients are suggested based on our experience and review of the literature...
  31. ncbi Geographic disparities in access to organ transplantation
    Peter J Morris
    Transplantation 76:1383. 2003
  32. ncbi Regulatory T cells finally get the attention they deserve
    Peter J Morris
    Transplantation 77:S2-3. 2004
  33. ncbi HLA in the allocation of cadaver kidneys: a global perspective
    Peter J Morris
    Transplantation 77:608. 2004
  34. ncbi Care of the live kidney donor: consensus on the ultimate gift
    Anthony P Monaco
    Transplantation 79:S51. 2005
  35. ncbi Reduction in calcineurin inhibitor exposure and maintenance of effective immunosuppression: clinical experience with everolimus (Certican)
    Anthony P Monaco
    Transplantation 79:S67-8. 2005
  36. ncbi Pancreatic islet transplantation: is the glass half-empty or half-full?
    Peter J Morris
    Transplantation 79:1287-8. 2005
  37. ncbi Evidence in transplantation: randomized versus nonrandomized studies
    Peter J Morris
    Transplantation 86:16-7. 2008